Gold Bullion or Cash?

By Editorial Team -

Comments

Post a Comment

Popular posts from this blog

Best AI Stocks & ETFs for 2026: Powering the Next Boom

By -
Image
Updated October 7, 2026 · Originally published December 2025 · By the One Day Advisor Editorial Team Prices and year-to-date (YTD) figures are as of the October 6, 2026 close unless another date is shown. Figures marked “est.” are unconfirmed. Quick Answer AI infrastructure stocks hit record highs in early October 2026, but returns are uneven. Nvidia (about $240, up roughly 28% this year) and AMD (up roughly 190%) lead; the VanEck Semiconductor ETF (SMH) is up about 76%; Vertiv sits a third below its record. The key risk is rates: the Fed hiked on September 16 and the 10-year yield touched 5.31%. TSMC reports October 15; the Fed decides October 28. Disclosure: This article is educational and is not financial or investment advice. It contains no affiliate or sponsored links. Other One Day Advisor pages may include Amazon Associates links, which are disclosed wher...
Read more

Top 30 Stocks to Buy and Hold in 2026: Best AI, Technology, Healthcare and Global Compounders

By -
Image
Reviewed by: Frank Yap, MBA | Written by: OneDayMBA Editorial Team | Originally published: July 2026 | Last updated: October 18, 2026 (market data through the October 16 close) The investing backdrop turned sharply in the week ended October 16, 2026. The S&P 500 and Nasdaq Composite had set record closes on October 6, then gave it back: the S&P 500 closed Friday at 7,659.44 and the Nasdaq at 26,140.03, both below their 50-day moving averages, while the Philadelphia Semiconductor Index posted its worst week since April 2025. That makes this a useful moment to restate what a long-term stock list is for. This is a multi-year, moat-and-growth ranking of 30 companies across AI infrastructure, memory, cloud, healthcare, payments and defensives, not a short-term trading list. Quick Answer: The best stocks to buy and hold in 2026 are quality compounders with durable moats: Nvidia, Alphabet, Microsoft, TSMC, Broadcom and Eli Lilly lead our ranking of 30. October's chip sell...
Read more

GLP-1 Investing Hub 2026: Eli Lilly, Novo Nordisk, Oral Pills, Compounding & Supply-Chain Stocks

By -
Image
By OneDayAdvisor Editorial Team  |  Published: October 14, 2026  |  Last updated: October 2026 Disclosure. This article is educational research, not investment, tax or medical advice. OneDayAdvisor is not a registered investment adviser, and nothing here is a recommendation to buy or sell any security. Company figures come from the sources listed at the end; verify against primary filings before acting. For patient-side guidance on these medicines, see the OneDayMD GLP-1 resource hub . QUICK ANSWER GLP-1 investing in October 2026 has four layers: the two incumbents (Eli Lilly, with Q3 revenue up 39% to $24.4 billion, and Novo Nordisk, with adjusted sales up 7%), the oral-pill race (Wegovy pill vs Foundayo), the compounding crackdown, and picks-and-shovels suppliers. Growth is volume-led while per-patient prices fall, so the key questions are valuation, pipeline timing and policy, not whether demand exists. [1] [4] On this page 1. Market snapshot: the numbe...
Read more